{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:49:43Z","timestamp":1761094183275,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.bbmt.2014.06.033","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T15:15:30Z","timestamp":1405005330000},"page":"1722-1728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Outcomes of Hematopoietic Cell Transplantation in Adult Patients with Acquired Aplastic Anemia Using Intermediate-Dose Alemtuzumab-Based Conditioning"],"prefix":"10.1016","volume":"20","author":[{"given":"Nada","family":"Hamad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Del Bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans A.","family":"Messner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kuruvilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieun","family":"Uhm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Seftel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naheed","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2014.06.033_bib1","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3324\/haematol.2010.026682","article-title":"Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors","volume":"95","author":"Gupta","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2014.06.033_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/bmt.2012.233","article-title":"Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression","volume":"48","author":"Bacigalupo","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib3","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood.V91.10.3637","article-title":"Long-term outcome after marrow transplantation for severe aplastic anemia","volume":"91","author":"Deeg","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.06.033_bib4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1182\/blood-2006-03-005041","article-title":"Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy","volume":"108","author":"Deeg","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.06.033_bib5","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1182\/blood-2003-07-2546","article-title":"Long-term outcome after bone marrow transplantation for severe aplastic anemia","volume":"103","author":"Ades","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.06.033_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/bbmt.2001.v7.pm11215697","article-title":"Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers","volume":"7","author":"Storb","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib7","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.291.19.2335","article-title":"Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma","volume":"291","author":"Syrjala","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2014.06.033_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.bmt.1704799","article-title":"Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning","volume":"35","author":"Gupta","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbmt.2004.09.001","article-title":"Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in\u00a0vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia","volume":"10","author":"Gupta","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbmt.2003.11.001","article-title":"Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab","volume":"10","author":"Avivi","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1046\/j.1365-2141.2002.03992.x","article-title":"Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality","volume":"119","author":"Chakrabarti","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.06.033_bib12","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1182\/blood.V99.12.4357","article-title":"High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution","volume":"99","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.06.033_bib13","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2010-12-327536","article-title":"Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia","volume":"118","author":"Marsh","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.06.033_bib14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.bmt.1705263","article-title":"Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival","volume":"37","author":"Juliusson","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/bmt.2008.88","article-title":"Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies","volume":"42","author":"Siegal","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib16","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1200\/JCO.2008.21.1128","article-title":"Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group","volume":"27","author":"Stilgenbauer","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.06.033_bib17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-02-0593","article-title":"Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration","volume":"104","author":"Hale","year":"2004","journal-title":"Blood"},{"year":"2009","series-title":"Campath Prescription Information","author":"Genzyme Corporation","key":"10.1016\/j.bbmt.2014.06.033_bib18"},{"key":"10.1016\/j.bbmt.2014.06.033_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.bmt.1705583","article-title":"Marrow transplantation for severe aplastic anemia with significant renal impairment","volume":"39","author":"Gerrie","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib20","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.06.033_bib21","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.06.033_bib22","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib24","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.06.033_bib25","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.bbmt.2010.04.005","article-title":"Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age","volume":"16","author":"Sangiolo","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2141.2012.09066.x","article-title":"Excellent outcome of\u00a0matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience","volume":"157","author":"Samarasinghe","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.06.033_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/bmt.2008.390","article-title":"Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by\u00a0infusion of ex\u00a0vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD","volume":"43","author":"Novitzky","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ajh.23392","article-title":"In\u00a0vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation","volume":"88","author":"Kanda","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2014.06.033_bib29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/sj.bmt.1705121","article-title":"Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with alemtuzumab","volume":"36","author":"Lamba","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1399-3062.2009.00414.x","article-title":"Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin","volume":"11","author":"Park","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2014.06.033_bib31","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","article-title":"CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation","volume":"369","author":"Marty","year":"2013","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.bbmt.2014.06.033_bib32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/bmt.2008.394","article-title":"Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia","volume":"43","author":"Buyck","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.06.033_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2141.2012.09070.x","article-title":"Management of autoimmune diseases after haematopoietic stem cell transplantation","volume":"157","author":"Holbro","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.06.033_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0092-8674(04)00335-6","article-title":"Homeostatic expansion of T cells during immune insufficiency generates autoimmunity","volume":"117","author":"King","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbmt.2014.06.033_bib35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1046\/j.1365-2141.2003.04721.x","article-title":"Guidelines for the diagnosis and management of acquired aplastic anaemia","volume":"123","author":"Marsh","year":"2003","journal-title":"Br J Haematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114004005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114004005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:49:31Z","timestamp":1761058171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879114004005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1083879114004005"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.06.033","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Hematopoietic Cell Transplantation in Adult Patients with Acquired Aplastic Anemia Using Intermediate-Dose Alemtuzumab-Based Conditioning","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}